Although S-1 regimens also showed a lower rate of grade 3-4 hand-foot syndrome compared to capecitabine regimens (0% versus 3%), this difference did not reach statistical significance.
← all excerpts
Capecitabine, 5-fluorouracil and S-1 based regimens for previously untreated advanced oesophagogastric cancer: A network meta-analysis.
1
—
—